SHOCKING: 4 | Mind Blowing Facts

India to procure 20 more doses of monoclonal antibody from Australia for Nipah treatment: ICMR chief

ICMR procuring 20 more doses of monoclonal antibody to treat Nipah virus in India; globally, 14 patients have survived after being administered the medicine. Mortality rate of Nipah virus is 40-70%, compared to 2-3% of COVID-19. Kerala govt, doctors & families to decide if antibody should be used. #ICMR #NipahVirus…

The Hindu · Sep 15, 2023

India ups Nipah surveillance, reaches out to Australia for monoclonal antibody doses

India to procure 20 more doses of monoclonal antibody for Nipah virus treatment. ICMR DG Rajeev Bahl says mortality rate is high (40-70%) compared to Covid (2-3%). All efforts are on to contain spread in Kerala. Monoclonal antibody has been given to 14 patients outside India and all survived.

The Hindu · Sep 15, 2023

‘Precautions, hygiene can keep Nipah virus at bay’

Dr. Roy advises taking precautions to reduce risk of Nipah virus infections. Washing hands, avoiding contact with animals, and limiting contact with infected people are key steps. ICMR is working to contain Nipah in restricted regions and raise awareness.

The Hindu · Sep 14, 2023

‘Evolution of scientific methodology is possible because of the human desire to know’

ICMR NITM launched "Kshitij: looking beyond the horizon", a lecture series in Belagavi. Nitin Khot delivered the inaugural address on evolutionary biology, contribution of scientists and dangers faced by present generation. ICMR NITM director said series aims to strengthen connections between institution and scholars, and help research be interdisciplinary. Khot…

The Hindu · Sep 8, 2023

At least single dose vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality: ICMR study

An ICMR study has found that at least one dose of vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality

The Hindu · Aug 21, 2023

India takes its first step towards opening door to CHIS

ICMR Bioethics Unit has proposed a consensus policy statement to introduce Controlled Human Infection Studies (CHIS) in India, which involves exposing healthy volunteers to pathogens in a controlled environment. The document addresses ethical concerns and outlines potential benefits, such as accelerating the development of novel medical interventions, improved pandemic preparedness,…

The Hindu · Jul 24, 2023

Sudden deaths of youth have been reported after COVID-19: Health Ministry in Lok Sabha

Health Ministry says sudden deaths of youth after COVID-19 unconfirmed and ICMR conducting 3 studies. Health Department is providing support to States/UTs

The Hindu · Jul 21, 2023

Advanced Mycology Diagnostic and Research Centre inaugurated at St. John’s Medical College

The Advanced Mycology Diagnostic and Research Centre (AMDRC) of the Indian Council of Medical Research (ICMR) was inaugurated at St. John’s Medical College and Hospital on Tuesday.

The Hindu · Jul 11, 2023

India keen to reduce import dependence on assistive technologies, ICMR DG

The Director-General of Indian Council of Medical Research (ICMR), Rajiv Bahl, on Saturday said that the Centre was keen on reducing the country’s dependence on import and provide high quality, affordable assistive technologies to every person in need

The Hindu · Jun 17, 2023

Age and co-morbidity are definite factors that affect COVID and its outcome, says ICMR head

Age and co-morbidity are definite factors that affect the outcome of contracting COVID-19, Rajiv Bahl, Director General of the Indian Council of Medical Research (ICMR), has said.

The Hindu · Jun 15, 2023